Natalie Bravo is an IPilogue Writer and a 2L JD Candidate at Osgoode Hall Law School.

��

Do you ever get weird emails that are poorly-veiled attempts? Strange requests for payments? These phishing attempts are occurring more frequently, but they are just the tip of the ransomware iceberg. Cybersecurity breaches are a serious concern and the ever-evolving technological landscape is an endless playing field for dedicated malicious actors. Widespread breaches exemplify the need to updated software and security policies across all sectors which use online services. With the pandemic and many working from home, these attacks are on the rise. The Canadian Centre for Cybersecurity reported that ransomware is an and

Many Canadians have not heard of , a malicious software (“”) that attacks computers by user files so that malicious actors can request monetary ransom to decrypt or unlock the files. These are typically, though not always, carried out by an unauthorized or unknown transfer of a Users may download and/or open a file that appears legitimate and unknowingly infect the operating system with malware. Accompanying ransom demands are usually requested in the form of Bitcoin due to the presumed anonymity of the transactions. The use of Bitcoin is rampant in these types of attacks – so much so that they have impacted (“K�۰�”) . Sometimes hackers . In a recent report, McCarthy Tétrault’s Cyber/Data Group estimated that Canadian organizations . Ransomware attacks damaging more than finances as they can disrupt operations and corrupt or destroy sensitive data. During the pandemic, hospitals are of utmost concern. The click of an ad, a visit to a website, or a simple file download could risk your data.

In 2017, a high-profile ransomware attack named devastated various organizations worldwide. The automatically spread throughout networkers and did not require users to open or download any files. It encrypted user files and demanded Bitcoin ransom payments to decrypt them. WannaCry targeted “end of life” or outdated versions of and exploited certain vulnerabilities within the software. Operating systems must frequently be updated to implement security patches that prevent such exploits. However, updates for older computers are usually discontinued as technology progresses. Microsoft quickly released further following the mass attack. The international event was and reported to have impacted more than 200,000 computer systems and caused an estimated hundreds of millions to billions of dollars in damage. The WannaCry attack affected organizations such as factories, telecommunication companies, hospitals, governments, and delivery systems. Years later, ��

WannaCry was terrifying when it happened, but many more concerning high-profile cybersecurity attacks have occurred ��within the past year . Just imagine . Some alarming events in the past three months include the following:

• In May 2021, the largest petroleum pipeline in the United States, Colonial Pipeline is reported to have been hacked via a . The password had access to the company’s internal network and was also unfortunately leaked on the dark web. The hackers utilized the credential to attack and extort Colonial Pipeline. The systems started to shut down and the ransom demanded was $4.4 million in payment. The company stated they had no choice but to
• In June 2021, one of the largest meat producers in the US, JBS made the difficult decision to pay the $11 million USD ransom in Bitcoin to resume plant operations.
• On July 4^th, 2021, the ‘,’ allegedly conducted by Russian-associated hackers REvil, hit during the US holiday weekend. Kaseya, a software firm, was targeted in the . Supply-chain attacks, in brief terms, involve compromising a trusted supplier therefore sabotaging the distribution system. The Kaseya attack largely affected US businesses, but Canada was also impacted. Between 800 and 1,500 organizations across the globe were impacted and essentially paralyzed. They demanded from affected users/companies and expressed some willingness to .

It is difficult to know what will happen next with technology, computers, and software. It is best to be proactive and cautious. I have compiled some tips, supported by and the , to help keep your data and your employer’s networks safe:

• Check your computer(s) for updates frequently, and make sure your operating system is still receiving new updates.
• Back up your data periodically and preferably offline. If you are targeted and your data becomes inaccessible, you will feel so much better knowing you had a back-up or two handy.
• Make sure you are running a trusted anti-virus program, sometimes they are installed on your computer.
• Understand how to your data in the event of a breach and practice the recovery methods.
• Keep your passwords safe and unique - reusing passwords is never a good idea.
• Familiarize yourself with common types and methods of malware. You can find a handy list .
• Contact your organization’s IT department whenever you see anything suspicious, just in case.

Stay safe, don’t interact with strange emails, and always update and backup if possible! Feel free to comment below any tips or advice you may have.

The post Cyber Horrors: Ransomware and You appeared first on IPOsgoode.

Photo Credit: Jon Tyson on Unsplash

Ryan Erdman is an��IPilogue��Writer and a 2L JD Candidate at��Osgoode��Hall Law School.��

��

��

In a truly monumental achievement in scientific innovation, there are now authorized COVID-19 vaccines around the globe. However, present inequities in global distribution plague the achievement and ultimate success of these vaccines in ending the pandemic. show that 87% of the over 1 billon doses administered worldwide have been in high-income countries, compared to only 0.2%��of doses administered in low-income countries. As world case numbers continue to rise, the presence and likelihood of variant strains only prolong the immediate harms and long-term impacts. If current trends persist, COVID-19 will continue to devastate countries with less developed and more permeable borders long after developed countries reach majority levels of immunization. At the current pace, it is some low-income countries will not see significant percentages of the population vaccinated until 2023.

The trends in inequitable global access to new medicines are not novel and have long been tied to the intellectual property (IP) rights granted to drug manufacturers in return for taking on the “risk” of research and development (R&D). In general, by awarding a period of limited exclusive rights during which the developer can set non-competitive prices, IP protections inherently and negatively impact affordability. At the beginning of the pandemic, costs and public sector investment affected the ability of high-and upper-middle-income countries to around 6 billion doses through advanced purchase agreements. In October, South Africa and India submitted a to the World Trade Organization (WTO) calling to temporarily waive the Trade-Related Aspects of the Intellectual Property Rights (TRIPS) Agreement provisions relevant to COVID-19 related technology, citing historical and present barriers in affordable and timely access to new medicines created by IP rights. Specifically, they call for a waiver of sections outlining the rights and obligations in the areas of copyright, industrial designs, patents, and the protection of trade secrets relating to “the preventing and treatment of COVID-19.”

The breadth of the original proposal is important in light of the Biden Administration’s recent supporting a waiver of IP rights. The announcement, however, does not directly support the waiver initially proposed 7 months ago. The scope of the initial waiver proposal was purposefully broad, looking to eliminate barriers created by IP protections related to accessibility of not just vaccines, but also other necessary technology in the areas of diagnostics, P.P.E., and other therapeutic drugs. The scope and duration of a waiver comprise many key issues that will need to be agreed to and countries have shown a to come to the negotiating table in light of the US announcement. Canada has that it will not block a waiver, and that the government is committed to work towards a “consensus-based” solution.

But where time is at a premium, the complexity and length of negotiations is an obvious cause of concern. Given the likelihood of COVID-19 becoming , including the persistent threat of variants, any waiver may significantly affect future innovation in COVID-19 “booster shots” and other vaccine technology. This is part of why Big Pharma has met the Biden Administration’s announcement with continuous and skepticism for the efficacy of any waiver in meeting the objective of timely increases in global production. The most prominent of these criticisms doubts that a waiver will effectively address the true bottlenecks, which is to be the scarcity of raw materials and ingredients and the lack of technical know-how.

This is particularly important in determining the scope of the waiver, as a vaccine “patent waiver”, as the media consistently calls it, is simply underinclusive of the knowledge transfer necessary. While a vaccine patent waiver could help alleviate obstacles around technology fragmentation, where different parties own multiple patents related to one vaccine, scaling up production in developing countries also requires the transfer of technical processes. This would involve numerous types of IP and requires technical expertise to build and implement. Some this is why, even though Moderna has long not to enforce certain COVID-19 patent rights during the pandemic, there has been “no flourishing of factories pumping out “generic” messenger-RNA vaccines.” New manufacturers would also need to generate a novel and comprehensive “”, as they cannot rely on the safety and efficacy clinical trial data of originators like with small molecule drugs. The original waiver addressed both copyright and trade secrets, but there are clear that any waiver is certainly going to be narrower than that originally proposed. Any “consensus-based solution”, if at all, will take months and not include the time for new producers to build production capacity and meet regulatory hurdles. WTO Director-General Ngozi Okonjo-Iweala recently expressed “hope” that a waiver could be agreed upon by .

Nonetheless, while accepting that a waiver may not be a “silver bullet” solution, the announcement has certainly reflected optimism for a critical shift in the status-quo, with the head of the WHO calling it a “monumental moment in the fight against COVID-19.” We could look back on this as the moment where high-income nations finally move-away from strong notions of “vaccine nationalism.” Timely access requires a unified effort and immediate, continued support from developed nations for global initiatives like the UN-backed , which plans to deliver billions of vaccines to low-income countries. Members on both sides of the waiver debate advocated for vaccine-producing nations increasing production and reducing restrictions on the export of vaccines (and materials). Interestingly, some that the threat of a waiver could also be a tactic to push companies into greater licensing strategies and persuade them to exhaust production capacity and sell extra supplies to poor countries. The perceived threat of compulsory licensing has pushed companies to make broader global pledges in the .

Where a pandemic is truly a “” every second matters, yet there are many reasons to believe that we will not feel the effects of any negotiations for a long time. Waiver discussions are sure to intensify ahead of the WTO’s next formal meeting in early June.

The post Biden Support for Covid-19 Intellectual Property Waiver: A Step Below Progress? appeared first on IPOsgoode.